v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Cash flows from operating activities:      
Net income $ 251,076 $ 172,561 $ 213,054
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 80,287 77,966 68,335
Stock-based compensation expense 47,961 39,970 36,285
Provision for doubtful accounts 20,676 20,715 22,493
Gain on marketable securities (17,105) (29,848) (2,874)
Gain on cash surrender value of life insurance policies (11,597) (8,803) (10,576)
Deferred income taxes (6,404) (32,309) (14,403)
Impairment of right-of-use assets 2,452 1,629 5,471
Impairment of fixed assets 509 1,575 4,375
Change in other assets and liabilities:      
Deferred compensation 41,462 65,402 52,291
Receivables due from clients (33,243) 7,872 33,483
Income taxes and other receivables 5,711 13,669 (25,615)
Prepaid expenses and other assets 7,997 (239) (5,884)
Unearned compensation (9,454) 7,923 11,904
Income taxes payable (5,349) 2,617 (15,304)
Accounts payable and accrued liabilities (1,976) (54,712) (27,821)
Other (8,641) (2,027) (1,320)
Net cash provided by operating activities 364,362 283,961 343,894
Cash flows from investing activities:      
Purchase of property and equipment (62,484) (55,147) (70,382)
Cash paid for acquisitions, net of cash acquired (44,442) 0 (254,750)
Proceeds from sales/maturities of marketable securities 41,921 46,000 65,878
Purchase of marketable securities (39,453) (45,768) (53,530)
Premium on company-owned life insurance policies (28,440) (15,185) (15,219)
Proceeds from life insurance policies 7,359 16,272 4,376
Dividends received from unconsolidated subsidiaries 40 0 150
Net cash used in investing activities (125,499) (53,828) (323,477)
Cash flows from financing activities:      
Dividends paid to shareholders (83,632) (54,391) (32,971)
Repurchases of common stock (88,819) (53,162) (95,463)
Payments of tax withholdings on restricted stock (17,351) (10,732) (22,232)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 7,868 8,347 7,606
Payments on life insurance policy loans (4,127) (123) (2,760)
Dividends paid to noncontrolling interest (3,038) (4,496) (4,721)
Principal payments on finance leases (1,631) (1,776) (1,639)
Net cash used in financing activities (190,730) (116,333) (152,180)
Effect of exchange rate changes on cash and cash equivalents 17,826 (16,819) (2,283)
Net increase (decrease) in cash and cash equivalents 65,959 96,981 (134,046)
Cash and cash equivalents at beginning of year 941,005 844,024 978,070
Cash and cash equivalents at end of the year 1,006,964 941,005 844,024
Supplemental cash flow information:      
Cash used to pay interest 25,249 24,992 25,409
Cash used to pay income taxes, net of refunds $ 106,900 $ 72,124 $ 134,741

Source

PDF